✦ LIBER ✦

Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA)

✍ Scribed by A. Eissa; I. Krass; B. V. Bajorek

Book ID: 114738702
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 515 KB
Volume: 37
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2012.01366.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of intravenous recombinant tissu

The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke

✍ Joseph H. Kahn; Jason Viereck; Carlos Kase; Thomas Jeerakathil; Rafael Romero; S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Intravenous recombinant tissue plasminog

Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis

✍ Samuel J. Maiser; Alexandros L. Georgiadis; M. Fareed K. Suri; Gabriela Vazquez; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

Thrombotic occlusion of the common carot

Thrombotic occlusion of the common carotid artery (CCA) in acute ischemic stroke treated with intravenous tissue plasminogen activator (TPA)

✍ V. K. Sharma; G. Tsivgoulis; A. Y. Lao; M. Flaster; J. L. Frey; M. D. Malkoff; A 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

The implementation of intravenous tissue

The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke – a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia

✍ Ad Hoc Committee representing the National Stroke Foundation; the Stroke Society 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

The benefits and harms of intravenous th

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 311 KB

Apolipoprotein E phenotype and the effic

Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke

✍ Joseph Broderick; Mei Lu; Christy Jackson; Arthur Pancioli; Barbara C. Tilley; S 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views